Clinical Trial Update: Safety Study of Preimplantation Factor (PIF-1) to Treat Acute Steroid-Resistant Graft-Versus-Host Disease (GVHD) [Phase 1]

View source ↗

Summary

Phase 1 safety study evaluating Preimplantation Factor (PIF-1) for treatment of acute steroid-resistant graft-versus-host disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Preimplantation Factor (PIF-1)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Graft Vs Host Disease | Phase 1 | Status: UNKNOWN